Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Chris Coleclough"'
Autor:
Ruth Ann Scroggs, Xiaoyan Zhan, Julia L. Hurwitz, Kelli L. Boyd, Cecilia Prouser, Sateesh Krishnamurthy, Allen Portner, Chris Coleclough, Brita Brown, Karen S. Slobod, Toru Takimoto
Publikováno v:
Viral Immunology. 18:255-266
Respiratory syncytial virus (RSV) is among the most important and serious pediatric respiratory diseases, and yet after more than four decades of research an effective vaccine is still unavailable. This review examines the role of the immune response
Autor:
Amy Zirkel, Brita Brown, Timothy D. Lockey, Julia L. Hurwitz, Peter C. Doherty, Robert E. Sealy, Karen S. Slobod, Xiaoyan Zhan, Pamela Freiden, Louis N. Martin, John Stambas, Bart G. Jones, Mattia Bonsignori, James Blanchard, Sherri L. Surman, Chris Coleclough, Scott A. Brown
Publikováno v:
Current HIV Research. 3:107-112
A central obstacle to the design of a global HIV vaccine is viral diversity. Antigenic differences in envelope proteins result in distinct HIV serotypes, operationally defined such that antibodies raised against envelope molecules from one serotype w
Autor:
Xiaoyan Zhan, Julia L. Hurwitz, Sateesh Krishnamurthy, Toru Takimoto, Ruth Ann Scroggs, Cecilia Prouser, Brita Brown, Yoshiyuki Nagai, Allen Portner, Karen S. Slobod, Chris Coleclough, Kelli L. Boyd
Publikováno v:
Journal of Virology. 78:6043-6047
Although RSV causes serious pediatric respiratory disease, an effective vaccine does not exist. To capture the strengths of a live virus vaccine, we have used the murine parainfluenza virus type 1 (Sendai virus [SV]) as a xenogeneic vector to deliver
Autor:
Chris Coleclough, Xiaoyan Zhan, Julia L. Hurwitz, Karen S. Slobod, Scott A. Brown, Sherri L. Surman
Publikováno v:
Vaccine. 22:1206-1213
HIV has thus far evaded control by vaccines, in part due to the high diversity among viral isolates. To effectively target HIV diversity, we propose that multi-envelope HIV vaccines should be designed. We hypothesize that minor components of complex
Autor:
Stephen W. White, Peter C. Doherty, Amy Zirkel, Sherri L. Surman, Xiaoyan Zhan, Julia L. Hurwitz, Karen S. Slobod, Scott A. Brown, Chris Coleclough, John Stambas
Publikováno v:
The Journal of Immunology. 171:4140-4148
A long-standing question in the field of immunology concerns the factors that contribute to Th cell epitope immunodominance. For a number of viral membrane proteins, Th cell epitopes are localized to exposed protein surfaces, often overlapping with A
Autor:
Karen S. Slobod, Timothy D. Lockey, Peter C. Doherty, Chris Coleclough, Sherri L. Surman, Scott A. Brown, Xiaoyan Zhan, Julia L. Hurwitz
Publikováno v:
Journal of Virology. 77:4231-4236
Single-envelope human immunodeficiency virus (HIV) vaccines have been studied for more than a decade, with some successes in homologous challenge experiments in nonhuman primates but with no clear successes in clinical trials. To gain insight into th
Autor:
Xiaoyan Zhan, Scott A. Brown, James Blanchard, Robert E. Sealy, Karen S. Slobod, Chris Coleclough, Mattia Bonsignori, Timothy D. Lockey, John Stambas, Julia L. Hurwitz, Louis N. Martin
Publikováno v:
Vaccine. 23(46-47)
A central obstacle to the design of a global HIV-1 vaccine is virus diversity. Pathogen diversity is not unique to HIV-1, and has been successfully conquered in other fields by the creation of vaccine cocktails. Here we describe the testing of an HIV
Autor:
Clive A. Slaughter, Karen S. Slobod, Amy Zirkel, Scott A. Brown, Timothy D. Lockey, Peter C. Doherty, Ashutosh Mishra, Sherri L. Surman, Julia L. Hurwitz, Chris Coleclough, Vishwajeeth Pagala
Publikováno v:
AIDS research and human retroviruses. 21(2)
Our previous work has shown that immunodominant T-helper cell epitopes cluster within distinct fragments on a single face of the HIV envelope gp120 protein. We show in this report that the general positions of immunodominant epitopes are shared by T
Autor:
Kim J Allison, Jorge Luján-Zilbermann, Allen Portner, Chris Coleclough, Julia L. Hurwitz, Karen S. Slobod, Ruth Ann Scroggs, Brita Brown, Jerry L. Shenep
Publikováno v:
Vaccine. 22(23-24)
Human parainfluenza virus-type 1 (hPIV-1) is the most common cause of pediatric laryngotracheobronchitis (croup) and results in close to 30,000 US hospitalizations each year [Ped. Inf. Dis. J. 20 (2001) 646]. No effective vaccine is available. We exa
Autor:
Xiaoyan Zhan, Julia L. Hurwitz, John Stambas, Bart G. Jones, Chris Coleclough, Karen S. Slobod, Robert E. Sealy, Brita Brown, Sherri L. Surman, Mattia Bonsignori, Amy Zirkel, Pamela Freiden, Scott A. Brown
Publikováno v:
AIDS Research and Therapy
AIDS Research and Therapy, Vol 2, Iss 1, p 3 (2005)
AIDS Research and Therapy, Vol 2, Iss 1, p 3 (2005)
Today, scientists are often encouraged to custom-design vaccines based on a particular country or clade. Here, we review the scientific literature and then suggest that the overwhelming endeavor to produce a unique vaccine for every world region or v